share_log

Ginkgo Bioworks | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Thomas F. Knight Jr.(4.1%)

Ginkgo Bioworks | SC 13G/A:超過5%持股股東披露文件(修正)-Thomas F. Knight Jr.(4.1%)

SEC announcement ·  02/14 17:15
Moomoo AI 已提取核心訊息
Thomas F. Knight Jr., a significant shareholder in Ginkgo Bioworks Holdings, Inc., has filed an amendment with the Securities and Exchange Commission indicating that he no longer holds more than five percent of the company's Class A Common Stock as of December 31, 2023. The filing, known as Amendment No. 3, serves as an exit filing for Knight. As detailed in the Schedule 13G, Knight reported beneficial ownership of 68,328,434 shares, representing 4.1% of the class, which includes direct ownership, shares issuable upon conversion of Class B Common Stock, and shares held by family trusts. The filing also clarifies that Knight has ceased to be the beneficial owner of more than five percent of the outstanding shares, marking a change in his investment position in the company.
Thomas F. Knight Jr., a significant shareholder in Ginkgo Bioworks Holdings, Inc., has filed an amendment with the Securities and Exchange Commission indicating that he no longer holds more than five percent of the company's Class A Common Stock as of December 31, 2023. The filing, known as Amendment No. 3, serves as an exit filing for Knight. As detailed in the Schedule 13G, Knight reported beneficial ownership of 68,328,434 shares, representing 4.1% of the class, which includes direct ownership, shares issuable upon conversion of Class B Common Stock, and shares held by family trusts. The filing also clarifies that Knight has ceased to be the beneficial owner of more than five percent of the outstanding shares, marking a change in his investment position in the company.
Ginkgo Bioworks Holdings, Inc.的大股東小托馬斯·奈特已向美國證券交易委員會提交了一項修正案,表明截至2023年12月31日,他持有的該公司A類普通股的比例已不再超過5%。該文件被稱爲第3號修正案,是奈特的退出申請。如附表13G所詳述,奈特報告了68,328,434股股票的受益所有權,佔該類別的4.1%,其中包括直接所有權、B類普通股轉換後可發行的股票以及家族信託持有的股份。該文件還澄清說,奈特已不再是超過5%的已發行股票的受益所有人,這標誌着他在該公司的投資狀況發生了變化。
Ginkgo Bioworks Holdings, Inc.的大股東小托馬斯·奈特已向美國證券交易委員會提交了一項修正案,表明截至2023年12月31日,他持有的該公司A類普通股的比例已不再超過5%。該文件被稱爲第3號修正案,是奈特的退出申請。如附表13G所詳述,奈特報告了68,328,434股股票的受益所有權,佔該類別的4.1%,其中包括直接所有權、B類普通股轉換後可發行的股票以及家族信託持有的股份。該文件還澄清說,奈特已不再是超過5%的已發行股票的受益所有人,這標誌着他在該公司的投資狀況發生了變化。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息